U.S. Markets closed

Bonus BioGroup Ltd. (BONS.TA)

Tel Aviv - Tel Aviv Delayed Price. Currency in ILA
Add to watchlist
103.40+1.30 (+1.27%)
At close: 05:24PM IST

Bonus BioGroup Ltd.

Matam Advanced Technology Park
POB 15143
Haifa 31905
972 7 320 67104

Full Time Employees32

Key Executives

NameTitlePayExercisedYear Born
Mr. Joseph Rauch M.B.A.Exec. Chairman1.4MN/A1957
Dr. Shai Meretzki Ph.D.Founder, CEO, Pres & Director1.95MN/A1969
Mr. Yoni Livne CPAChief Financial Officer710kN/A1975
Dr. Vered KivityHead of Regulatory AffairsN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in ILA.


Bonus BioGroup Ltd., a biotechnology company, develops technology solutions to generate tissue-regenerating bone grafts. It develops tissue-regenerating bone grafts from cells derived from the patient's own cells for the treatment of skeletal disorders, such as bone trauma and arthritis. The company's products include BonoFill injectable bone graft that is suitable for bone repair applications, including jaw bone cysts; and BonoFill pre-designed bone graft, which is used to repair large and segmental bone defects. Its products in pipeline comprise bone grafts for maxillofacial and orthopedic applications; novel nanomaterials technology for tissue regeneration; and large vascularized bone grafts. The company was formerly known as Oceana Advanced Industries Ltd. and changed its name to Bonus BioGroup Ltd. Bonus BioGroup Ltd. was founded in 1981 and is based in Haifa, Israel.

Corporate Governance

Bonus BioGroup Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.